Although it remains unclear whether CD138-negative myeloma cells are ‘myeloma stem cells’, several reports have shown that CD138-low or -negative cells may contribute to drug resistance or relapse of the disease (9,11,12). The gene discussed is SDC1; the disease is plasma cell myeloma.